CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease

Since its discovery in 2012, CRISPR Cas9 has been tried as a direct treatment approach to correct the causative gene mutation and establish animal models in neurodegenerative disorders. Since no strategy developed until now could completely cure Parkinson's disease (PD), neuroscientists aspire...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinjala, Poojitha, Tryphena, Kamatham Pushpa, Prasad, Renuka, Khatri, Dharmendra Kumar, Sun, Woong, Singh, Shashi Bala, Gugulothu, Dalapathi, Srivastava, Saurabh, Vora, Lalitkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190035/
https://www.ncbi.nlm.nih.gov/pubmed/37194005
http://dx.doi.org/10.1186/s40824-023-00381-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190035/
https://www.ncbi.nlm.nih.gov/pubmed/37194005
http://dx.doi.org/10.1186/s40824-023-00381-y

Ejemplares similares